Stable, high-level expression of human serotonin receptors in L929 cells using an inducible expression system

Receptors and Channels

Volumn 5, Issue 3-4, 1997, Pages 125-137

  Vanhoenacker, P ^a   Gommeren, W ^b   Luyten, W H M L ^b   Leysen, J E ^b   Haegeman, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Alniditan; Inducible expression; Mx promoter; Serotonin receptors

Indexed keywords

ALNIDITAN; ANTIMIGRAINE AGENT; BETA INTERFERON; CHLORAMPHENICOL ACETYLTRANSFERASE; COMPLEMENTARY DNA; INTERFERON; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN L 929; CONTROLLED STUDY; DNA TRANSFECTION; GENE INDUCTION; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE;

ANIMALIA; FELIS CATUS; MURINAE;

EID: 0031394016     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Boshart M Klüppel M Schmidt A Schütz G and Luckow B (1992) Gene 110 129-130.
2. Bradford MM (1976) Anal. Biochem. 72 248-254.
3. David M (1995) Pharmacol. Ther. 65 149-161.
4. Demchyshyn L Sunahara RK Miller K Teitler M Hoffman BJ Kennedy JL Seeman P Van Tol HHM and Niznik HB (1992) Proc. Natl. Acad. Sci. USA 89 5522-5526.
5. Fargin A Raymond JR Lohse MJ Kobilka BK Caron MG and Lefkowitz RJ (1988) Nature 335 358-360.
6. Fargin A Raymond JR Regan JW Cotecchia S Lefkowitz RJ and Caron MG (1989) J. Biol. Chem. 264 14848-14852.
7. Grotewiel MS and Sanders-Bush E (1994) J. Neurochem. 63 1255-1260.
8. Hamblin MW Metcalf MA McGuffin RW and Karpells S (1992) Biochem. Biophys. Res. Commun 184 752-759.
9. Hartig PR Hoyer D Humphrey PPA and Martin GR (1996) Trends Pharmacol. Sci. 17 103-105.
10. Horisberger MA McMaster GK Zeller H Wathelet MG Dellis J and Content J (1990) J. Virol. 64 1171-1181.
11. Hoyer D Clarke DE Fozard JR Hartig PR Martin GR Mylecharane EJ Saxena PR and Humphrey PP (1994) Pharmacol. Rev. 46 157-203.
12. Hug H Costas M Staeheli P Aebi M and Weissmann C (1988) Mol. Cell. Biol. 8 3065-3079.
13. Jin H Oksenberg D Ashkenazi A Peroutka SJ Duncan AMV Rozmahel R Yang Y Mengod G Palacios JM and O'Dowd BF (1992) J. Biol. Chem. 267 5735-5738.
14. Kobilka BK Frielle T Collins S Yang-Feng T Kobilka TS Francke U Lefkowitz RJ and Caron MG (1987) Nature 329 75-79.
15. Lew FO Gudermann T Birnbaumer M Kaumann AJ and Birnbaumer L (1992a) FEBS Lett. 296 201-206.
16. Levy FO Gudermann T Perez-Reyes E Birnbaumer M Kaumann AJ and Birnbaumer L (1992b) J. Biol. Chem. 267 7553-7562.
17. Leysen JE Niemegeers CJE Van Nueten JM and Laduron PM (1982) Mol. Pharmacol. 21 301-314.
18. Leysen JE Gommeren W Mertens J Luyten WHML Pauwels PJ Ewert M and Seeburg P (1993) Psychopharmacology 110 27-36.
19. Leysen JE Schotte A Janssen PMF Gommeren W Van Gompel P Lesage AS De Backer MD Luyten WHML Amlaiky N and Megens AAHP (1995) Schizophrenia, Alfred Benzon Symposium 38 344-356.
20. Leysen JE Gommeren W Heylen L Luyten WHML Van De Weyer I Vanhoenacker P Haegeman G Schotte A Van Gompel P Wouters R and Lesage AS (1996) Mol. Pharmacol. 50 1567-1580
21. Lleonart R Näf D Browning H and Weissmann C (1990) Bio/Technology 8 1263-1267.
22. Luyten WHML and Leysen JE (1993) Trends Biotechnol. 11 247-254.
23. McAllister G Charlesworth A Snodin C Beer MS Noble AJ Middlemiss DN Iversen LL and Whiting P (1992) Proc. Natl. Acad. Sci. USA 89 5517-5521.
24. Meier E Fäh J Grob MS End R Staeheli P and Haller O (1988) J. Virol. 62 2386-2393.
25. Mertens J Terriere D Sipido V Gommeren W Janssen PMF and Leysen JE (1994) Journal of Labelled Compounds and Radiopharmaceuticals 34 795-806.
26. Pauwels PJ Van Gompel P and Leysen JE (1993) Biochem. Pharmacol. 45 375-383.
27. Pavlovic J Zürcher T Haller O and Staeheli P (1990) J. Virol. 64 3370-3375.
28. Reid LE Brasnett AH Gilbert CS Porter ACG Gewert DR Stark GR and Kerr IM (1989) Proc. Natl. Acad. Sci. USA 86 840-844.
29. Saltzman AG Morse B Whitman MM Ivanshchenko Y Jaye M and Felder S (1991) Biochem. Biophys. Res. Commun. 181 1469-1478
30. Schotte A Janssen PMF Gommeren W Luyten WHML Van Gompel P Lesage AS De Loore K and Leysen JE (1996) Psychopharmacology 124 57-73.
31. Southern PJ and Berg P (1982) J. Mol. Appl. Genet. 1 327-341.
32. Staeheli P Horisberger MA and Haller O (1984) Virology 132 456-461.
33. Staeheli P Haller O Boll W Lindenmann J and Weissmann C (1986a) Cell 44 147-158.
34. Staeheli P Danielson P Haller O and Sutcliffe JG (1986b) Mol. Cell. Biol. 6 4770-4774.
35. Stratowa C Himmler A and Czernilofsky AP (1995) Curr. Opin. Biotech. 6 574-581.
36. Van Lommen G De Bruyn M Schroven M Verschueren W Janssens W Verrelst J and Leysen JE (1995) Bioorganic & Medicinal Chemistry Letters 5 2649-2654.
37. Vanden Berghe W Haegeman G and Fiers W (1993) Arch. Intern. Physiol. Biochim. Biophys. 101 B35
38. Vanhoenacker P Fiers W and Haeaeman G (1994) Eur. Cytokine Netw. 5 283-291.
39. Varrault A Journot L Audigier Y and Bockaert J (1992) Mol. Pharmacol. 41 999-1007.
40. Weinshank RL Zgombick JM Macchi MJ Branchek TA and Hartig PR (1992) Proc. Natl. Acad. Sci. USA 89 3630-3634.
41. Zaworski PG Evans DL Lahti RA and Gill GS (1995) J. Neurosci. Methods 56 169-175.
42. Zgombick JM Schechter LE Macchi M Hartig PR Branchek TA and Weinshank RL (1992) Mol. Pharmacol. 42 180-185.
43. Zürcher T Pavlovic J and Staeheli P (1992) Virology 187 796-800.